Oncogenes and surgical pathology.

The discovery of oncogenes began with identification of genetic material in viruses capable of causing neoplasia in animals. Through processes of "transduction" and "insertional mutagenesis," RNA/retroviruses may (1) alter directly, (2) alter expression of, or (3) move pieces of host cellular genome in ways that they become potential agents of neoplastic transformation. The pieces of host cellular genome, either affected in situ by viral gene insertion or transduced by the virus, are known as oncogenes. Approximately 20 oncogenes have been identified. Although they have yet to be proven to be sufficient or necessary for neoplastic transformation, the evidence for their playing a part in the transformation process is mounting. The functions of the protein products of the various oncogenes are closely related to those of proteins involved in normal cell regulatory and cycle activities. Study of the oncogene products and their functions serves to elucidate the basic character of neoplasia. The functional classes of oncogenes with specific examples of genomic amplification, altered mRNA or protein product expression, or mutational deletion associated with human neoplasia are reviewed herein. Since the techniques for detecting oncogene DNA and mRNA alterations are rapidly becoming a part of our diagnostic armamentarium, surgical pathologists should be prepared for the imminent use of such molecular techniques and information in diagnosis and prognosis of human neoplasia.